Tributary Capital Management’s CONMED CNMD Stock Holding History

Tributary Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.42M	Buy	257,180 +8,203	+3%	+$295K	0.69%	62
2026 Q1	$8.8M	Sell	248,977 -19,919	-7%	-$810K	0.85%	56
2025 Q4	$10.9M	Buy	268,896 +61,060	+29%	+$2.66M	1.08%	48
2025 Q3	$9.77M	Buy	+207,836	New	+$10.8M	0.88%	58
2014 Q4	–	Sell	-79,430	Closed	-$2.93M	–	166
2014 Q3	$2.93M	Buy	79,430 +5,375	+7%	+$213K	0.61%	85
2014 Q2	$3.27M	Sell	74,055 -24,551	-25%	-$1.11M	0.65%	83
2014 Q1	$4.28M	Sell	98,606 -256	-0.3%	-$11.4K	0.9%	28
2013 Q4	$4.2M	Sell	98,862 -217	-0.2%	-$8.25K	0.83%	33
2013 Q3	$3.37M	Buy	99,079 +18,893	+24%	+$616K	0.69%	57
2013 Q2	$2.5M	Buy	+80,186	New	+$2.6M	0.41%	122

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Tributary Capital Management's CNMD Position: Q2 2026 in Review

Tributary Capital Management increased its CONMED (CNMD) stake by 3.3% in Q2 2026, buying an estimated $295K and bringing the position to 257,180 shares worth $8.42M. The position accounts for 0.69% of the portfolio, ranked #62.

Tributary Capital Management first reported a position in CNMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $10.9M in Q4 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Tributary Capital Management held 257,180 shares of CONMED worth $8.42M as of Q2 2026.
Tributary Capital Management bought 8,203 CONMED shares in Q2 2026, an estimated $295K.
CONMED made up 0.69% of Tributary Capital Management's portfolio in Q2 2026, its #62 holding.
Tributary Capital Management first reported a position in CONMED in Q2 2013 and has held it in 10 quarters since.
Tributary Capital Management's CONMED position peaked at $10.9M in Q4 2025.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Tributary Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.